Moorfields Eye Charity is an independent charity which supports pioneering eye health work at Moorfields Eye Hospital NHS Foundation Trust ("Moorfields") and the UCL Institute of Ophthalmology which, combined, is the oldest and largest centre for ophthalmic treatment, teaching and research in Europe.
The charity's mission is to improve eye health by funding innovation in research, education and patient care to benefit Moorfields’ patients. Over the last year alone, it has awarded £6.4m in grants to support these aims. Ambitious strategic aims for the coming decade are set out in its recent Strategy 2021-2027, with a focus on being the leading charity for research into eye health, supporting patient care and sharing knowledge, and playing a role in shaping national policy.
Moorfields Eye Charity's vision is that its support enables Moorfields and UCL to provide world-leading eye care, research and education from a new integrated centre for advancing eye health called Oriel. Oriel will be located on a site near St Pancras in the Kings Cross Knowledge Quarter; it is a partnership between Moorfields, UCL and the charity. The joint fundraising campaign with UCL is on track to raise £100m towards the cost of Oriel, with construction planned to start in 2023 and the centre expected to open in 2027.
Investments
The charity has total assets of c. £65m (as at 30/9/22) comprising: a long-term investment portfolio of c. £46m; a shorter term ‘Oriel’ investment portfolio of £15.5m for some of the funds committed towards the capital construction costs of Oriel; and a short-term portfolio representing its cash / working capital.
Following a review of its investment strategy in October 2020, the Board decided to have the portfolio managed wherever possible on a basis which explicitly incorporates sustainable considerations. The transition to sustainable investments was completed in May 2021.
Please find more information about the charity's investments in its Annual Report and Accounts 2021-22, about the impact of its work in its Impact Report 2022, and about Oriel here.